Expression and modulation of CD44 variant isoforms in humans

Charles R. Mackay, Hans Joachim Terpe, Reinhard Stauder, Wendy L. Marston, Heike Stark, Ursula Günthert

Research output: Contribution to journalArticleResearchpeer-review

391 Citations (Scopus)

Abstract

CD44 is a ubiquitous surface molecule that exists as a number of isoforms, generated by alternative splicing of 10 'variant' exons. Little is known about the expression and function of the variant isoforms, except that certain isoforms may play a role in cancer metastasis. We produced mAbs against CD44 variant regions encoded by exons 4v, 6v, and 9v, by immunizing mice with a fusion protein spanning variant exons 3v to 10v. A comprehensive analysis of human tissues revealed that CD44 variant isoforms were expressed widely throughout the body, principally by epithelial cells. However there was differential expression of CD44 variant exons by different epithelia. Most epithelia expressed exon 9v, but much fewer expressed 6v or 4v. The regions of epithelia that expressed the highest levels of the variant isoforms were the generative cells, particularly the basal cells of stratified squamous epithelium, and of grandular epithelium. CD44 variant isoforms were also expressed differentially by leukocytes, with CD44-9v expressed at very low levels and CD44-6v and 4v virtually absent. However, CD44-9v and CD44-6v were the main variants that were transiently upregulated on T cells after mitogenic stimulation and on myelomonocytic cell lines by TNFα and IFN-γ treatment. Some epithelial cell lines could preferentially upregulate CD44-6v upon IFNγ incubation. These results show that CD44 variant isoforms are expressed much more widely than first appreciated, and that expression of the variant isoforms on some cell types can be modulated by particular cytokines.

Original languageEnglish
Pages (from-to)71-82
Number of pages12
JournalJournal of Cell Biology
Volume124
Issue number1-2
DOIs
Publication statusPublished - 1 Jan 1994
Externally publishedYes

Cite this